Creso Pharma Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COPHF research report →
About the company
Creso Pharma Limited is a global pharmaceutical company focused on the development, registration, and commercialization of advanced cannabis and hemp-based solutions. These therapeutic products and nutraceuticals are designed for both human and animal health applications, with market presence spanning Europe, the Middle East, North America, and the Asia Pacific region. Beyond innovative product creation, the company also manages the cultivation, processing, and distribution of cannabis products, extending its reach to the retail sector.
- CEO
- William Lay
- IPO
- 2017
- HQ
- Nedlands, WA, AU
Price Chart
- Market Cap
- $131.72M
- P/E
- -0.40
- P/S
- 2.66
- P/B
- 0.59
- EV/EBITDA
- -0.94
- Div Yield
- 0.00%
- Gross Margin
- 3.30%
- Op Margin
- -225.19%
- Net Margin
- -377.28%
- ROE
- -130.99%
- ROIC
- -67.55%
- Revenue
- $18.92M · 117.76%
- Net Income
- $-52,446,000 · -59.98%
- EPS
- $0.00 · 100.00%
- Op Income
- $-16,680,000
- FCF YoY
- 72.89%
- 52W High
- $9.47
- 52W Low
- $0.00
- 50D MA
- $0.12
- 200D MA
- $0.07
- Beta
- -24.81
- Avg Volume
- 0
Get TickerSpark's AI analysis on COPHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our COPHF coverage
Recent articles, reports, and earnings notes.
No research on COPHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate COPHF report →Similar companies
Peers in the same neighborhood.